Literature DB >> 20202440

Influenza A pandemic (H1N1) 2009 virus infection in domestic cat.

Brett A Sponseller1, Erin Strait, Albert Jergens, Jessie Trujillo, Karen Harmon, Leo Koster, Melinda Jenkins-Moore, Mary Killian, Sabrina Swenson, Holly Bender, Ken Waller, Kristina Miles, Tracy Pearce, Kyoung Jin Yoon, Peter Nara.   

Abstract

Influenza A pandemic (H1N1) 2009 virus continues to rapidly spread worldwide. In 2009, pandemic (H1N1) 2009 infection in a domestic cat from Iowa was diagnosed by a novel PCR assay that distinguishes between Eurasian and North American pandemic (H1N1) 2009 virus matrix genes. Human-to-cat transmission is presumed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20202440      PMCID: PMC3322044          DOI: 10.3201/eid1603.091737

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Influenza viruses are typically host specific; aquatic birds are considered the primary reservoir. However, interspecies transmission does occur (–) and occasionally leads to novel host-adapted strains. Interspecies transmission of influenza virus has been a public health concern because of the possibility that, through reassortment, a novel strain with zoonotic potential could emerge. The recent infection of dogs with equine influenza virus (H3N8) () and of swine with human influenza virus (H1N2) () are particularly intriguing because the former resulted in influenza becoming endemic in dogs and the latter resulted in a documented reassortment event between human and swine influenza viruses. Such concern has escalated with the recent emergence of the novel quadruple-reassorted influenza virus (H1N1) [pandemic (H1N1) 2009] in humans (). Although infection and transmission of the virus have occurred primarily among humans, occasional transmission from infected persons to susceptible animals (e.g., swine, turkeys, ferrets) has been documented (). The likelihood of pandemic (H1N1) 2009 infection of domestic pets has been considered less likely (www.cdc.gov/h1n1flu/qa.htm,www.avma.org/public_health/influenza/new_virus/default.asp,www.usda.gov/wps/portal/?navid=USDA_H1N1); however, we report a confirmed case of pandemic (H1N1) 2009 virus infection in a domestic cat that had been in contact with persons who had recently experienced influenza-like illness.

The Case

A 13-year-old, castrated male, domestic cat that lived indoors in a single-cat household was brought to the Iowa State University Lloyd Veterinary Medical Center because of depression, inappetance, and respiratory signs of 4 days’ duration. The cat was gregarious and interacted closely with family members in the household. The family members noted that the cat was reluctant to lie in lateral recumbency and instead rested in sternal recumbency with neck extended, which was indicative of dyspnea. The cat’s vaccination status was up to date. Before the onset of clinical signs in the cat, 2 of the 3 family members had experienced an undiagnosed influenza-like illness—an upper respiratory tract infection characterized by fever, coughing, and myalgia—that lasted 3 days. Onset of the cat’s clinical signs was noted 6 and 4 days after onset of illness for the first and second family members, respectively. At the time of examination, the cat had bilateral adventitial lung sounds (wheezes), was afebrile, and was clinically dehydrated. Radiographs of the thorax showed a bilateral caudodorsal alveolar pattern (Figure). Cytologic and microbiologic examination of bronchoalveolar lavage (BAL) fluid showed foamy macrophages (65%), nondegenerate neutrophils (25%), and small lymphocytes (10%). Clinicopathologic findings suggested a moderate, predominantly macrophagic, mixed inflammatory process. Standard microbial culture of BAL aliquots yielded no substantial growth of aerobic or anaerobic bacteria. Radiographic and cytologic findings were inconsistent with bacterial or parasitic pneumonia and not supportive of allergic airway disease. A viral cause was considered most likely; however, the cat was given amoxicillin with clavulanate (125 mg orally 2×/day) to reduce the possibility of secondary bacterial pneumonia. Notable findings from laboratory testing (complete blood count, serum biochemistry, urinalysis, and total thyroxine measurement) were moderate leukopenia characterized by a moderate lymphopenia, modest hemoconcentration, and a slightly elevated thyroxine level. Lymphopenia was consistent with acute viral infection.
Figure

Radiographs of the thorax of a cat with confirmed influenza A pandemic (H1N1) 2009 virus infection. A) Right lateral view; B) dorsoventral view. Asymmetric soft tissue opacities are evident in the right and left caudal lung lobes. An alveolar pattern, composed of air bronchograms with border-effaced (indistinct) adjacent pulmonary vessels, is most pronounced in the left caudal lobe. A small gas lucency in the pleural space appears in the right caudal and dorsal thoracic cavity. An endotracheal tube is visible at the thoracic inlet on the lateral view in this moderately obese cat. L, left.

Radiographs of the thorax of a cat with confirmed influenza A pandemic (H1N1) 2009 virus infection. A) Right lateral view; B) dorsoventral view. Asymmetric soft tissue opacities are evident in the right and left caudal lung lobes. An alveolar pattern, composed of air bronchograms with border-effaced (indistinct) adjacent pulmonary vessels, is most pronounced in the left caudal lobe. A small gas lucency in the pleural space appears in the right caudal and dorsal thoracic cavity. An endotracheal tube is visible at the thoracic inlet on the lateral view in this moderately obese cat. L, left. PCR testing (Feline URD Panel; Idexx Laboratories, Westbrook, ME, USA) of a BAL sample showed negative results for Chlamydophila felis, feline calicivirus, feline herpesvirus-1, Bordetella bronchiseptica, and Mycoplasma felis. Results of feline immunodeficiency virus (antibody) and feline leukopenia virus (antigen) testing (Idexx SNAP FIV/FeLV Combo Test; Idexx Laboratories) were also negative, ruling out the potential that viral-induced immunosuppression was a concurrent factor. For the following reasons we included pandemic (H1N1) 2009 on our list of differential diagnoses: recent history of respiratory disease in household family members, known widespread community prevalence of pandemic (H1N1) 2009 influenza in humans, paucity of common viral infections causing infectious caudodorsal alveolar pneumonia in adult cats, and documented susceptibility of felids to avian influenza (H5N1) (,). We therefore submitted a BAL sample to the Iowa State University Veterinary Diagnostic Laboratory for molecular screening and typing for influenza A and the pandemic (H1N1) 2009 virus. RNA was obtained from the BAL fluid by using the MagMAX Viral RNA Isolation Kit (Applied Biosystems, Austin, TX, USA) and a semiautomated magnetic particle processor (Kingfisher 96; Thermo Electron Corp., Woodstock, GA, USA) according to manufacturer’s recommendations. Molecular testing used a real-time reverse transcription–PCR (rRT-PCR) influenza A screening assay specific for the nucleoprotein gene. Preliminary differentiation of pandemic (H1N1) 2009 virus from other H1 or H3 types of influenza A was performed by using an in-house rRT-PCR assay that distinguishes between pandemic (H1N1) 2009 [Eurasian matrix ()] and endemic (to North America) swine H1N1 influenza viruses (North American matrix). Sequences of primers and probes are summarized in Table 1. PCRs were conducted by using the AgPath-ID Multiplex One-Step RT-PCR Kit (Ambion/Applied Biosystems) according to manufacturer’s recommendations; 10 units of Multiscribe Reverse Transcriptase (Applied Biosystems) were added per reaction. Thermocycling was performed by using the Applied Biosystems 7500 Fast Real-Time PCR System according to manufacturer’s recommendations.
Table 1

Oligonucleotide sequences for primers and probes and dye labels used in novel molecular testing for pandemic (H1N1) 2009 virus, Iowa State University Veterinary Diagnostic Laboratory, Ames, Iowa, USA, 2009*

NameSequence (5′ → 3′)Description
Influenza A NP screening assay
SIVRTFCGGACGAAAAGGCAACGANP forward primer
SIVRTRCTGCATTGTCTCCGAAGAAATAAGNP reverse primer
SIVRTP
CCGATCGTGCCYTC
NP probe, MGB FAM
Pandemic influenza M differentiation assay
M_FTCAGGCCCCCTCAAAGCM forward primer
M_R1CATTCCATGAGAGCCTCAAGATCM reverse primer 1
M_R1aCACTCCATGAGAGCCTCAAGATCM reverse primer 2
M_R1bCATTCCATGAGTGCCTCAAGATCM reverse primer 3
M_EUPrCAGAGACTGGAAAGTGTEU M MGB, VIC
M_NAPrCAGAGACTYGAAGAYGTNA M MGB, FAM

*Primers and MGB probes were obtained from Integrated DNA Technologies (Coralville, IA, USA) and Applied Biosystems Inc. (Foster City, CA, USA), respectively. SIV, swine influenza virus; NP, nucleoprotein; M, matrix.

*Primers and MGB probes were obtained from Integrated DNA Technologies (Coralville, IA, USA) and Applied Biosystems Inc. (Foster City, CA, USA), respectively. SIV, swine influenza virus; NP, nucleoprotein; M, matrix. PCR testing showed the BAL sample to be positive for influenza A virus (nucleoprotein gene), and the virus was determined to contain the matrix (M) gene of the pandemic (H1N1) 2009 virus strain. A BAL sample was submitted to the US Department of Agriculture National Veterinary Services Laboratories (Ames, IA, USA) for confirmatory testing. rRT-PCR confirmed that the BAL sample was positive for the M gene of influenza A virus and the neuraminidase (N) gene of pandemic (H1N1) 2009 virus. Sequences of primers and probes are summarized in Table 2. A cytolytic virus was isolated by using MDCK cells () and was designated as A/feline/IA/NVSL026991/2009. PCR testing of the isolate for influenza A virus (M gene) and N1 gene of pandemic (H1N1) 2009 showed positive results. Sequence analyses for hemagglutinin (HA), N, and M genes confirmed that the virus was pandemic (H1N1) 2009 virus (GenBank accession nos. GU332630 (for HA), GU332632 (for NA), and GU332631 (for M). Nucleotide homologies with the first US human pandemic (H1N1) 2009 isolate (A/CA/04/2009) were 99.4%, 99.4%, and 99.8% for the HA, NA, and M genes, respectively.
Table 2

Oligonucleotide sequences for primers and probes and dye labels used in confirmatory molecular testing for pandemic (H1N1) 2009 virus, National Veterinary Services Laboratories, Ames, Iowa, USA, 2009*

NameSequence (5′ → 3′)Description
Influenza A M screening assay
M+25AGATGAGTCTTCTAACCGAGGTCGAI M forward primer
M-124TGCAAAAACATCTTCAAGTCTCTGAI M reverse primer
M-124sivTGCAAAGACACTTTCCAGTCTCTGH1N1 M reverse primer

*Primers and probes were obtained from Integrated DNA Technologies (Coralville, IA, USA) and Biosearch Technologies, Inc. (Novato, CA, USA), respectively. M, matrix; AI, avian influenza; N, neuraminidase.

*Primers and probes were obtained from Integrated DNA Technologies (Coralville, IA, USA) and Biosearch Technologies, Inc. (Novato, CA, USA), respectively. M, matrix; AI, avian influenza; N, neuraminidase. The cat was discharged from the medical center after diagnostic testing and correction of dehydration. A veterinarian (B.A.S.) visited the home to monitor the cat’s clinical status and administer subcutaneous fluids (120–160 mL) until the cat’s appetite improved; adventitial lung sounds resolved within 3 days. Reassessment 1 week later showed marked improvement of clinical signs but only modest improvement of the lymphopenia and radiographic findings.

Conclusions

Because the cat was from a single-animal household and remained indoors, he was presumably infected through contact with the family members. Attempts to retrospectively confirm pandemic (H1N1) 2009 infection in the family members have been unsuccessful, but additional testing of archived biologic samples is being conducted. Although more surveillance and studies are needed to determine susceptibility of companion animals to the pandemic (H1N1) 2009 virus, possible reverse zoonotic transmission (humans to animals) remains a concern. Indeed, cases in a domestic dog and other felids have been confirmed () (www.cdc.gov/h1n1flu/qa.htm,www.avma.org/public_health/influenza/new_virus/default.asp, www.usda.gov/wps/portal/?navid=USDA_H1N1). Implications of pandemic (H1N1) 2009 virus infection in companion animals are 1) apparent human-to-animal transmission; 2) broader host range for the virus; 3) potential endemic establishment of influenza in companion animals; 4) possible transmission of influenza from companion animals to other species, including humans; and 5) the need to reevaluate companion animals as potential reservoirs or intermediate hosts for reassortment of influenza virus. This case emphasizes the need for close monitoring for interspecies transmission of influenza virus and reinforces the need for collaboration among many disciplines, a cornerstone of the One Health Initiative (www.onehealthinitiative.com).
  12 in total

1.  Characterization of a Canadian mink H3N2 influenza A virus isolate genetically related to triple reassortant swine influenza virus.

Authors:  Carl A Gagnon; Grant Spearman; Andre Hamel; Dale L Godson; Audrey Fortin; Guy Fontaine; Donald Tremblay
Journal:  J Clin Microbiol       Date:  2008-12-30       Impact factor: 5.948

2.  Naturally occurring influenza infection in a ferret (Mustela putorius furo) colony.

Authors:  Abby R Patterson; Vickie L Cooper; Kyoung-Jin Yoon; Bruce H Janke; Phillip C Gauger
Journal:  J Vet Diagn Invest       Date:  2009-07       Impact factor: 1.279

3.  Transmission of equine influenza virus to dogs.

Authors:  P C Crawford; Edward J Dubovi; William L Castleman; Iain Stephenson; E P J Gibbs; Limei Chen; Catherine Smith; Richard C Hill; Pamela Ferro; Justine Pompey; Rick A Bright; Marie-Jo Medina; Calvin M Johnson; Christopher W Olsen; Nancy J Cox; Alexander I Klimov; Jacqueline M Katz; Ruben O Donis
Journal:  Science       Date:  2005-09-26       Impact factor: 47.728

4.  Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts.

Authors:  Guus F Rimmelzwaan; Debby van Riel; Marianne Baars; Theo M Bestebroer; Geert van Amerongen; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

5.  Genetic reassortment of avian, swine, and human influenza A viruses in American pigs.

Authors:  N N Zhou; D A Senne; J S Landgraf; S L Swenson; G Erickson; K Rossow; L Liu; K j Yoon; S Krauss; R G Webster
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  Avian H5N1 influenza in cats.

Authors:  Thijs Kuiken; Guus Rimmelzwaan; Debby van Riel; Geert van Amerongen; Marianne Baars; Ron Fouchier; Albert Osterhaus
Journal:  Science       Date:  2004-09-02       Impact factor: 47.728

7.  Identification of human H1N2 and human-swine reassortant H1N2 and H1N1 influenza A viruses among pigs in Ontario, Canada (2003 to 2005).

Authors:  Alexander I Karasin; Suzanne Carman; Christopher W Olsen
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

8.  Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Authors:  Rebecca J Garten; C Todd Davis; Colin A Russell; Bo Shu; Stephen Lindstrom; Amanda Balish; Wendy M Sessions; Xiyan Xu; Eugene Skepner; Varough Deyde; Margaret Okomo-Adhiambo; Larisa Gubareva; John Barnes; Catherine B Smith; Shannon L Emery; Michael J Hillman; Pierre Rivailler; James Smagala; Miranda de Graaf; David F Burke; Ron A M Fouchier; Claudia Pappas; Celia M Alpuche-Aranda; Hugo López-Gatell; Hiram Olivera; Irma López; Christopher A Myers; Dennis Faix; Patrick J Blair; Cindy Yu; Kimberly M Keene; P David Dotson; David Boxrud; Anthony R Sambol; Syed H Abid; Kirsten St George; Tammy Bannerman; Amanda L Moore; David J Stringer; Patricia Blevins; Gail J Demmler-Harrison; Michele Ginsberg; Paula Kriner; Steve Waterman; Sandra Smole; Hugo F Guevara; Edward A Belongia; Patricia A Clark; Sara T Beatrice; Ruben Donis; Jacqueline Katz; Lyn Finelli; Carolyn B Bridges; Michael Shaw; Daniel B Jernigan; Timothy M Uyeki; Derek J Smith; Alexander I Klimov; Nancy J Cox
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

9.  Avian influenza H5N1 in naturally infected domestic cat.

Authors:  Thaweesak Songserm; Alongkorn Amonsin; Rungroj Jam-on; Namdee Sae-Heng; Noppadol Meemak; Nuananong Pariyothorn; Sunchai Payungporn; Apiradee Theamboonlers; Yong Poovorawan
Journal:  Emerg Infect Dis       Date:  2006-04       Impact factor: 6.883

10.  Transmission of avian influenza virus (H3N2) to dogs.

Authors:  Daesub Song; Bokyu Kang; Chulseung Lee; Kwonil Jung; Gunwoo Ha; Dongseok Kang; Seongjun Park; Bongkyun Park; Jinsik Oh
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

View more
  41 in total

1.  Combination of PB2 271A and SR polymorphism at positions 590/591 is critical for viral replication and virulence of swine influenza virus in cultured cells and in vivo.

Authors:  Qinfang Liu; Chuanling Qiao; Henju Marjuki; Bhupinder Bawa; Jingqun Ma; Stephane Guillossou; Richard J Webby; Jürgen A Richt; Wenjun Ma
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  A comprehensive laboratory animal facility pandemic response plan.

Authors:  Gordon S Roble; Naomi M Lingenhol; Bryan Baker; Amy Wilkerson; Ravi J Tolwani
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-09       Impact factor: 1.232

3.  Pandemic and seasonal human influenza virus infections in domestic cats: prevalence, association with respiratory disease, and seasonality patterns.

Authors:  A Ali; J B Daniels; Y Zhang; A Rodriguez-Palacios; K Hayes-Ozello; L Mathes; C-W Lee
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

4.  Restored PB1-F2 in the 2009 pandemic H1N1 influenza virus has minimal effects in swine.

Authors:  Lindomar Pena; Amy L Vincent; Crystal L Loving; Jamie N Henningson; Kelly M Lager; Alessio Lorusso; Daniel R Perez
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

5.  Faecal virome of cats in an animal shelter.

Authors:  Wen Zhang; Linlin Li; Xutao Deng; Beatrix Kapusinszky; Patricia A Pesavento; Eric Delwart
Journal:  J Gen Virol       Date:  2014-07-30       Impact factor: 3.891

6.  Pathology and viral antigen distribution of lethal pneumonia in domestic cats due to pandemic (H1N1) 2009 influenza A virus.

Authors:  C V Löhr; E E DeBess; R J Baker; S L Hiett; K A Hoffman; V J Murdoch; K A Fischer; D M Mulrooney; R L Selman; W M Hammill-Black
Journal:  Vet Pathol       Date:  2010-04-09       Impact factor: 2.221

7.  PB2-588I enhances 2009 H1N1 pandemic influenza virus virulence by increasing viral replication and exacerbating PB2 inhibition of beta interferon expression.

Authors:  Zongzheng Zhao; Chenyang Yi; Lianzhong Zhao; Shengyu Wang; Lishan Zhou; Yong Hu; Wei Zou; Huanchun Chen; Meilin Jin
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

8.  Pandemic H1N1 influenza virus infection in a Canadian cat.

Authors:  Cameron G Knight; Jennifer L Davies; Tomy Joseph; Sarah Ondrich; Brielle V Rosa
Journal:  Can Vet J       Date:  2016-05       Impact factor: 1.008

9.  Descriptive epidemiology of upper respiratory disease and associated risk factors in cats in an animal shelter in coastal western Canada.

Authors:  Nadine Gourkow; James H Lawson; Sara C Hamon; Clive J C Phillips
Journal:  Can Vet J       Date:  2013-02       Impact factor: 1.008

10.  A Novel A(H7N2) Influenza Virus Isolated from a Veterinarian Caring for Cats in a New York City Animal Shelter Causes Mild Disease and Transmits Poorly in the Ferret Model.

Authors:  Jessica A Belser; Joanna A Pulit-Penaloza; Xiangjie Sun; Nicole Brock; Claudia Pappas; Hannah M Creager; Hui Zeng; Terrence M Tumpey; Taronna R Maines
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.